Drug information for RIFAMPIN AND ISONIAZID
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE; ORAL
150MG;300MG
Prescription
AB
ISONIAZID
;
RIFAMPIN
rifamazid
WESTWARD
65221
Drug Adverse Effects information for RIFAMPIN AND ISONIAZID
Role code
Indications
Reaction
# Reports
PS
PULMONARY TUBERCULOSIS
MYALGIA
1
PS
TUBERCULOSIS
BLOOD IMMUNOGLOBULIN G INCREASED
1
PS
TUBERCULOSIS
DRUG INTERACTION
1
SS
BREAST CANCER METASTATIC
ANAEMIA
2
SS
BREAST CANCER METASTATIC
CAESAREAN SECTION
2
SS
BREAST CANCER METASTATIC
MATERNAL EXPOSURE DURING PREGNANCY
4
SS
BREAST CANCER METASTATIC
PREMATURE BABY
2
SS
BREAST CANCER METASTATIC
PREMATURE DELIVERY
2
SS
LYMPH NODE TUBERCULOSIS
ERYTHEMA
5
SS
LYMPH NODE TUBERCULOSIS
EYELID OEDEMA
5
SS
LYMPH NODE TUBERCULOSIS
FLUSHING
5
SS
LYMPH NODE TUBERCULOSIS
LICHENOID KERATOSIS
5
SS
LYMPH NODE TUBERCULOSIS
PRURITUS
5
SS
LYMPH NODE TUBERCULOSIS
RASH
5
SS
LYMPH NODE TUBERCULOSIS
RASH MACULAR
5
SS
LYMPH NODE TUBERCULOSIS
SKIN EXFOLIATION
5
SS
LYMPH NODE TUBERCULOSIS
SKIN TOXICITY
5
SS
LYMPH NODE TUBERCULOSIS
URTICARIA
5
SS
MATERNAL EXPOSURE DURING PREGNANCY
ANAEMIA
11
SS
MATERNAL EXPOSURE DURING PREGNANCY
MATERNAL EXPOSURE DURING PREGNANCY
11
SS
MATERNAL EXPOSURE DURING PREGNANCY
PREMATURE BABY
11
SS
MULTIPLE MYELOMA
BLOOD IMMUNOGLOBULIN G INCREASED
6
SS
PLEUROPERICARDITIS
AGITATION
8
SS
PLEUROPERICARDITIS
ARRHYTHMIA
4
SS
PLEUROPERICARDITIS
CONFUSIONAL STATE
8
SS
PLEUROPERICARDITIS
DYSKINESIA
8
SS
PLEUROPERICARDITIS
SUDDEN DEATH
4
SS
PRODUCT USED FOR UNKNOWN INDICATION
AGITATION
32
SS
PRODUCT USED FOR UNKNOWN INDICATION
ARRHYTHMIA
16
SS
PRODUCT USED FOR UNKNOWN INDICATION
CAESAREAN SECTION
9
SS
PRODUCT USED FOR UNKNOWN INDICATION
CONFUSIONAL STATE
32
SS
PRODUCT USED FOR UNKNOWN INDICATION
DYSKINESIA
32
SS
PRODUCT USED FOR UNKNOWN INDICATION
MATERNAL EXPOSURE DURING PREGNANCY
9
SS
PRODUCT USED FOR UNKNOWN INDICATION
PREMATURE DELIVERY
9
SS
PRODUCT USED FOR UNKNOWN INDICATION
SUDDEN DEATH
16
SS
PROPHYLAXIS
BICYTOPENIA
1
SS
PROPHYLAXIS
BONE MARROW LEUKAEMIC CELL INFILTRATION
1
SS
PROPHYLAXIS
FIBROSIS
1
SS
PROPHYLAXIS
HAIRY CELL LEUKAEMIA
1
SS
PROPHYLAXIS
NEUTROPENIA
1
SS
PROPHYLAXIS
PLATELET COUNT DECREASED
1
SS
PULMONARY TUBERCULOSIS
PERIARTHRITIS
3
SS
TUBERCULOSIS
BLOOD IMMUNOGLOBULIN G INCREASED
2
C
ANALGESIC THERAPY
INJECTION SITE CYST
1
C
ANALGESIC THERAPY
LIPODYSTROPHY ACQUIRED
1
C
ANKYLOSING SPONDYLITIS
DYSKINESIA
1
C
ANKYLOSING SPONDYLITIS
INJECTION SITE CYST
1
C
ANKYLOSING SPONDYLITIS
LIPODYSTROPHY ACQUIRED
1
C
ANKYLOSING SPONDYLITIS
TOOTH ABSCESS
1
C
ANTIBIOTIC PROPHYLAXIS
INJECTION SITE CYST
1
C
ANTIBIOTIC PROPHYLAXIS
LIPODYSTROPHY ACQUIRED
1
C
ANXIETY
BIPOLAR I DISORDER
1
C
ANXIETY
PRURITUS GENERALISED
1
C
ANXIETY
PSYCHOTIC DISORDER
2
C
GASTRITIS
INJECTION SITE CYST
1
C
GASTRITIS
LIPODYSTROPHY ACQUIRED
1
C
GENITAL HERPES
BLOOD THYROID STIMULATING HORMONE INCREASED
1
C
GENITAL HERPES
CYTOMEGALOVIRUS TEST POSITIVE
1
C
GENITAL HERPES
DEAFNESS NEUROSENSORY
2
C
GENITAL HERPES
LOW BIRTH WEIGHT BABY
2
C
GENITAL HERPES
MATERNAL EXPOSURE DURING PREGNANCY
2
C
GENITAL HERPES
PREMATURE RUPTURE OF MEMBRANES
1
C
HYPERTENSION
COLON CANCER
1
C
HYPOTHYROIDISM
COLON CANCER
1
C
MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE
COLON CANCER
1
C
PSORIASIS
BIPOLAR I DISORDER
1
C
PSORIASIS
COLON CANCER
3
C
PSORIASIS
PRURITUS GENERALISED
1
C
PSORIASIS
PSYCHOTIC DISORDER
2
C
PSORIASIS
THROMBOCYTOPENIA
1
C
RHEUMATOID ARTHRITIS
BODY MASS INDEX INCREASED
2
C
RHEUMATOID ARTHRITIS
GASTRIC BANDING
2
C
TUBERCULOSIS
BIPOLAR I DISORDER
1
C
TUBERCULOSIS
BLOOD THYROID STIMULATING HORMONE INCREASED
2
C
TUBERCULOSIS
CYTOMEGALOVIRUS TEST POSITIVE
2
C
TUBERCULOSIS
DEAFNESS NEUROSENSORY
4
C
TUBERCULOSIS
DYSKINESIA
1
C
TUBERCULOSIS
LOW BIRTH WEIGHT BABY
4
C
TUBERCULOSIS
MATERNAL EXPOSURE DURING PREGNANCY
4
C
TUBERCULOSIS
PREMATURE RUPTURE OF MEMBRANES
2
C
TUBERCULOSIS
PRURITUS GENERALISED
1
C
TUBERCULOSIS
PSYCHOTIC DISORDER
2
C
TUBERCULOSIS
THROMBOCYTOPENIA
1
C
TUBERCULOSIS
TOOTH ABSCESS
1
C
TYPE 2 DIABETES MELLITUS
COLON CANCER
3
Ads by Google